drugset / Trial / NCT00720902
Adult Growth Hormone Deficiency and Cardiovascular Risk
Non-randomizedParallel-groupOpen-labelOther
Summary
This protocol will assess the cardiovascular risk associated with growth hormone deficiency in adults. We will use multiple modalities to assess risk for heart attacks or strokes including blood work, ultrasound, MRI and endothelial cell biopsies in both patients who are growth hormone deficient and in patients with normal growth hormone secretion. We hypothesize that adults with growth hormone deficiency will have results suggestive of an increased risk for cardiovascular disease.
Timeline
- Start
- 2007-02
- Primary completion
- 2010-03
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Growth Hormone Releasing Hormone | Unknown | — | Intravenous |
| Comparator | L-arginine | Small molecule | — | Intravenous |